# Lamassu Pharma, LLC — Form D

Lamassu Pharma, LLC of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2020-05-04. The offering totals $2.9M, of which $2.7M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2020-05-04
- Form: D
- Accession: 0001810800-20-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.9M
- Amount sold: $2.7M
- Remaining: $235K
- Minimum investment: $50K
- Investors: 19
- Date of first sale: 2020-04-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-366203

## Issuer

- Name: Lamassu Pharma, LLC
- CIK: 0001810800
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 3520 KANGAROO DRIVE, DURHAM, NC, 27715
- Phone: 919-667-8571

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Gabi Hanna | Director | Durham, NC |
| Rabi Hanna | Director | Durham, NC |
| Gregory Palmer | Director | Durham, NC |
| Gabi Hanna | Executive Officer | Durham, NC |

## More

- [CIK 1810800 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1810800&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001810800-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.